MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

CUSIP: 62855J104

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93,057,750
Total 13F shares
75,541,156
Share change
+2,081,252
Total reported value
$3,474,992,493
Put/Call ratio
137%
Price per share
$46.00
Number of holders
278
Value change
+$111,969,670
Number of buys
141
Number of sells
105

Quarterly Holders Quick Answers

What is CUSIP 62855J104?
CUSIP 62855J104 identifies MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2018

As of 30 Sep 2018, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by 278 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,541,156 shares. The largest 10 holders included BlackRock Inc., BAILLIE GIFFORD & CO, Vanguard Group Inc, D. E. Shaw & Co., Inc., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, FRONTIER CAPITAL MANAGEMENT CO LLC, ACADIAN ASSET MANAGEMENT LLC, Thrivent Financial for Lutherans, and NORTHERN TRUST CORP. This page lists 278 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.